Bank of Montreal
CCCC icon

Bank of Montreal’s C4 Therapeutics CCCC Stock Holding History

Bank of Montreal’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,200
Closed -$34.6K – 3550
2025
Q2 		$34.6K Buy
24,200
+3,400
+16% +$4.95K ﹤0.01% 3208
2025
Q1 		$33.3K Sell
20,800
-3,650
-15% -$10.9K ﹤0.01% 3137
2024
Q4 		$88K Sell
24,450
-29,666
-55% -$148K ﹤0.01% 2984
2024
Q3 		$319K Buy
54,116
+34,816
+180% +$210K ﹤0.01% 2730
2024
Q2 		$90.9K Buy
+19,300
New +$115K ﹤0.01% 3266
2024
Q1 		– Sell
-76,800
Closed -$463K – 3923
2023
Q4 		$463K Buy
+76,800
New +$175K ﹤0.01% 2557
2022
Q1 		– Sell
-54,100
Closed -$1.78M – 4153
2021
Q4 		$1.78M Buy
+54,100
New +$2.14M ﹤0.01% 1641
2021
Q2 		– Sell
-291
Closed -$10K – 3860
2021
Q1 		$10K Sell
291
-1,376
-83% -$54.7K ﹤0.01% 4362
2020
Q4 		$62K Buy
+1,667
New +$48.3K ﹤0.01% 3837

Other funds holding CCCC

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of Montreal's CCCC Position: Q3 2025 in Review

Bank of Montreal sold out of C4 Therapeutics (CCCC) in Q3 2025, closing a stake of 24,200 shares — an estimated $34.6K sold.

Bank of Montreal first reported a position in CCCC in Q4 2020 and held it in 9 quarters. The position peaked at $1.78M in Q4 2021. 97 funds tracked by Wall St. Rank hold CCCC as of Q3 2025.

  • Bank of Montreal reported no remaining C4 Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Bank of Montreal sold 24,200 C4 Therapeutics shares in Q3 2025, an estimated $34.6K.
  • Bank of Montreal first reported a position in C4 Therapeutics in Q4 2020 and held it in 9 quarters.
  • Bank of Montreal's C4 Therapeutics position peaked at $1.78M in Q4 2021.
  • 97 funds tracked by Wall St. Rank held C4 Therapeutics as of Q3 2025.

Based on Bank of Montreal's 13F filing for Q3 2025, filed 13 Nov 2025.